Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a CAR T-cell therapy targeting CD19 and BCMA in autoimmune conditions, with recruiting status and potential indications includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Iga Nephropathy
• Nephrotic Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• CD19/BCMA CAR-T Cell Therapy

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Autoimmune Diseases, Systemic Lupus Erthematosus (SLE) | Phase 1 | Status: RECRUITING